Process for purifying proteins

Patent metadata

Field	Value
Publication number	US-9751930-B2
Application number	US-201113812350-A
Country	US
Kind code	B2
Filing date	Jul 27, 2011
Priority date	Jul 27, 2010
Publication date	Sep 5, 2017
Grant date	Sep 5, 2017

Abstract

The present invention provides method for purifying a recombinant protein from a gram-negative bacterial host cell sample or extract thereof wherein said host cell expresses a recombinant protein and a recombinant disulphide isomerase DsbC; comprising: a. adjusting the pH of the host cell sample or extract thereof to a pH of 5 or less to precipitate the recombinant disulphide isomerase; and b. separating precipitated recombinant disulphide isomerase DsbC from the recombinant protein to produce a recombinant protein sample.

First claim

The invention claimed is:

1. A method for purifying a recombinant protein of interest from gram-negative bacterial host cells, wherein said gram-negative bacterial host cells express the recombinant protein of interest and a recombinant disulphide isomerase, wherein the method comprises:
collecting said gram-negative bacterial host cells from culture medium;
releasing said recombinant protein of interest and said recombinant disulphide isomerase from said collected gram-negative bacterial host cells to form a gram-negative bacterial host cell extract;
separating said gram-negative bacterial host cells from the released recombinant protein of interest in said gram-negative bacterial host cell extract to form a liquid gram-negative bacterial host cell extract, wherein the pH of the liquid gram-negative bacterial host cell extract is lower than the pI of the recombinant protein of interest;
adjusting the pH of the liquid gram-negative bacterial host cell extract to a pH of 5 or less to precipitate the recombinant disulphide isomerase from the recombinant protein of interest, which remains in solution; and
separating the precipitated recombinant disulphide isomerase from the recombinant protein of interest remaining in solution to produce a liquid recombinant protein sample containing a reduced quantity of recombinant disulphide isomerase compared to the quantity of recombinant disulphide isomerase prior to said separating step.

2. The method according to claim 1 , wherein the pH of the liquid gram-negative bacterial host cell extract is adjusted to a pH of 4.5 or less.

3. The method according to claim 2 , wherein the pH of the liquid gram-negative bacterial host cell extract is adjusted to a pH of 4.5 to 3.0.

4. The method according to claim 2 , wherein the pH of the liquid gram-negative bacterial host cell extract is adjusted to a pH of 3 or less.

5. The method according to claim 1 , wherein the step of separating the precipitated recombinant disulphide isomerase from the recombinant protein of interest remaining in solution comprises centrifuging said liquid gram-negative bacterial host cell extract to separate the precipitate from the recombinant protein of interest to form said liquid recombinant protein sample and purifying said liquid recombinant protein of interest from said recombinant protein sample by chromatography.

6. The method according to claim 1 , wherein the disulphide isomerase comprises a histidine tag.

7. The method according to claim 1 , wherein the gram-negative bacterial host cells are Escherichia coli cells.

8. The method according to claim 1 , wherein the gram-negative bacterial host cells comprise FKBP-type peptidyl-prolyl cis-trans isomerase (Fkpa) and/or seventeen kilodalton protein (Skp).

9. The method according to claim 1 , wherein the pH of the liquid gram-negative bacterial host cell extract is adjusted to less than 5 using glacial acetic acid.

10. The method according to claim 1 , wherein the liquid gram-negative bacterial host cell extract is held at a pH of 5 or less for one hour or less.

11. The method according to claim 1 , wherein separating the precipitated recombinant disulphide isomerase from the recombinant protein of interest comprises centrifugation and/or filtration.

12. The method according to claim 1 , said method further comprising a purification step of subjecting the liquid recombinant protein sample to chromatography.

13. The method according to claim 12 , wherein the chromatography is ion-exchange chromatography.

14. The method according to claim 1 , wherein the pH of the liquid recombinant protein sample is adjusted to a pH of 5 to 7.

15. The method according to claim 1 , wherein releasing said recombinant protein of interest and said recombinant disulphide isomerase from said gram-negative bacterial host cells to form a gram-negative bacterial host cell extract comprises adding an extraction buffer to the gram-negative bacterial host cell extract and heating the gram-negative bacterial host cell extract/extraction buffer composition.

16. The method according to claim 1 , wherein the recombinant protein of interest has a pI of 6 to 9.

17. The method according to claim 16 , wherein the recombinant protein of interest has a pI of 8 to 9.

18. The method according to claim 1 , wherein the recombinant protein of interest is a recombinant antibody.

19. The method according to claim 18 , wherein the recombinant antibody is a monoclonal, humanized or chimeric antibody, or a binding fragment thereof.

20. The method according to claim 19 , wherein the binding fragment is a Fab or Fab′ fragment.

21. The method according to claim 18 , wherein the recombinant antibody is specific for human TNFα.

22. The method according to claim 21 , wherein the antibody comprises a heavy chain wherein the variable domain comprises a CDR having the sequence given in SEQ ID NO: 1 for CDRH1, SEQ ID NO: 2 for CDRH2, and SEQ ID NO: 3 for CDRH3 and a light chain and wherein the variable domain comprises a CDR having the sequence given in SEQ ID NO: 4 for CDRL1, SEQ ID NO: 5 for CDRL2 and SEQ ID NO: 6 for CDRL3.

23. The method according to claim 22 , wherein the antibody comprises the light chain variable region sequence given in SEQ ID NO: 7 and the heavy chain variable region sequence given in SEQ ID NO: 8.

24. The method according to claim 23 , wherein the antibody is a Fab fragment and comprises a heavy chain having the sequence given in SEQ ID NO: 10 and a light chain having the sequence given in SEQ ID NO: 9.

25. The method of claim 1 , wherein the recombinant disulphide isomerase is disulphide isomerase A (DsbA), disulphide isomerase B (DsbB), disulphide isomerase C (DsbC), disulphide isomerase D (DsbD) or disulphide isomerase G (DsbG).

26. The method of claim 25 , wherein the recombinant disulphide isomerase is disulphide isomerase C (DsbC).

27. The method according to claim 5 , wherein the chromatography is ion-exchange chromatography.

28. The method according to claim 15 , wherein said releasing said recombinant protein of interest and said recombinant disulphide isomerase from said gram negative bacterial host cells to form a gram-negative bacterial host cell extract comprises:
adding the extraction buffer to said gram-negative bacterial host cells separated from the culture medium to form the gram-negative bacterial host cell extract;
heating the gram-negative bacterial host cell extract to which said extraction buffer has been added to a temperature of 50° C. to 60° C. for a period of 10 to 16 hours;
centrifuging said heat treated gram-negative bacterial host cell extract/extraction buffer to separate gram-negative bacterial host cells from extracted material in the supernatant and collecting said supernatant;
adjusting the pH of said supernatant to between 3 and 5 to precipitate disulphide isomerase in said supernatant;
centrifuging the pH adjusted supernatant to separate precipitated disulphide isomerase from soluble proteins in said supernatant to form a recombinant protein sample;
optionally adjusting the pH of said recombinant protein sample to a pH of 5 to 7; and
purifying said recombinant protein of interest from said recombinant protein sample by column chromatography.

29. The method according to claim 15 , wherein releasing said recombinant protein of interest and said recombinant disulphide iso

Assignees

• Wild Gavin Barry
• Ucb Pharma Sa

Inventors

• Wild Gavin Barry

Classifications

• C07K1/36

  by a combination of two or more processes of different types · CPC title

• C07K2317/14

  Specific host cells or culture conditions, e.g. components, pH or temperature · CPC title

• C07K14/475

  Growth factors; Growth regulators · CPC title

• C07K2317/55

  Fab or Fab' · CPC title

• C12N9/90

  Isomerases (5.) · CPC title